ArticleThrombosis journal2019

Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease.

Ramy M Hanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.